TELMISARTAN JL telmisartan 40 mg tablets blister pack

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Ingredientes ativos:

telmisartan, Quantity: 40 mg

Disponível em:

Arrotex Pharmaceuticals Pty Ltd

Forma farmacêutica:

Tablet

Composição:

Excipient Ingredients: sodium hydroxide; povidone; meglumine; mannitol; magnesium stearate

Via de administração:

Oral

Unidades em pacote:

56 tablets, 14 tablets, 28 tablets, 30 tablets, 7 tablets (sample), 98 tablets

Tipo de prescrição:

(S4) Prescription Only Medicine

Indicações terapêuticas:

Telmisartan is indicated for: Treatment of hypertension. Prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see CLINICAL TRIALS).

Resumo do produto:

Visual Identification: White to off-white, oblong, un-coated tablets about 11.90 mm in length, 5.80mm width with 'C' debossed on one side and '04' debossed on the other side; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Status de autorização:

Registered

Data de autorização:

2019-03-14